Tekla Healthcare Opportunies Fund said on April 10, 2023 that its board of directors declared a regular
monthly dividend of $0.11 per share ($1.35 annualized).
Previously, the company paid $0.11 per share.
Shares must be purchased before the ex-div date of April 19, 2023 to qualify for the dividend.
Shareholders of record as of April 20, 2023
will receive the payment on April 28, 2023.
At the current share price of $19.32 / share,
the stock’s dividend yield is 6.99%.
Looking back five years and taking a sample every week, the average dividend yield has been
7.05%,
the lowest has been 5.33%,
and the highest has been 11.61%.
The standard deviation of yields is 0.86 (n=236).
The current dividend yield is
0.07 standard deviations
below
the historical average.
The company has not increased its dividend in the last three years.
Learn to Harvest Dividends
Buy Stock. Capture Dividend. Sell Stock. Repeat. This is the essence of dividend harvesting and you can
do it easily with Fintel’s Dividend Capture Calendar.
What is the Fund Sentiment?
There are 93 funds or institutions reporting positions in Tekla Healthcare Opportunies Fund.
This is an increase
of
5
owner(s) or 5.68% in the last quarter.
Average portfolio weight of all funds dedicated to THQ is 0.36%,
an increase
of 288.92%.
Total shares owned by institutions increased
in the last three months by 3.80% to 8,710K shares.
What are Other Shareholders Doing?
Janney Montgomery Scott
holds 94K shares.
In it’s prior filing, the firm reported owning 89K shares, representing
an increase
of 4.96%.
The firm
decreased
its portfolio allocation in THQ by 99.90% over the last quarter.
Cambridge Investment Research Advisors
holds 60K shares.
In it’s prior filing, the firm reported owning 59K shares, representing
an increase
of 2.22%.
The firm
increased
its portfolio allocation in THQ by 2.69% over the last quarter.
Us Bancorp \de\
holds 0K shares.
No change in the last quarter.
Raymond James & Associates
holds 909K shares.
In it’s prior filing, the firm reported owning 898K shares, representing
an increase
of 1.17%.
The firm
increased
its portfolio allocation in THQ by 0.37% over the last quarter.
CoreCap Advisors
holds 0K shares.
In it’s prior filing, the firm reported owning 0K shares, representing
an increase
of 100.00%.
Tekla Healthcare Opportunities Fund Background Information
(This description is provided by the company.)
Tekla Healthcare Opportunities Fund is a closed-end fund that invests in companies in the healthcare industry. Tekla Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund. Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
